stockrowAptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.
- Revenue
- +6.03%
- EPS
- −73.9%
- Free cash flow
- −16.9%
- Total debt
- +14.6%
Quarter to September 2026, against a year earlier
Follow ATR
Alert me
AptarGroup, Inc. (ATR) Return on assets
AptarGroup, Inc.'s return on assets over the twelve months to 30 September 2026 was 5.23%, down 2.9 percentage points from fiscal 2025 (8.11%). Over the past ten years it has ranged from 5.67% (fiscal 2020) to 8.43% (fiscal 2024); the current reading is higher than 73% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 8.11% | (0.32) |
| FY2024 | 8.43% | 1.86 |
| FY2023 | 6.57% | 0.83 |
| FY2022 | 5.74% | (0.26) |
| FY2021 | 6.00% | 0.33 |
| FY2020 | 5.67% | (1.31) |
| FY2019 | 6.98% | 1.00 |
| FY2018 | 5.98% | (1.68) |
| FY2017 | 7.66% | (0.49) |
| FY2016 | 8.15% | (0.03) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| ALGN Align Technology, Inc. compare | 7.71% |
| ATR AptarGroup, Inc. | 5.23% |
| COO The Cooper Companies, Inc. compare | 4.55% |
| AVTR Avantor, Inc. compare | 2.89% |
| SOLV Solventum Corporation compare | 1.11% |
| RGEN Repligen Corporation compare | −0.40% |
| BLCO Bausch + Lomb Corporation compare | −0.80% |
| BAX Baxter International Inc. compare | −3.57% |
| TFX Teleflex Incorporated compare | −14.6% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on ATR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement